7.40MMarket Cap-205P/E (TTM)
3.5000High3.0600Low21.75KVolume3.3100Open3.2900Pre Close71.70KTurnover1.51%Turnover RatioLossP/E (Static)2.11MShares20.255052wk High1.61P/B5.03MFloat Cap2.530052wk Low--Dividend TTM1.44MShs Float800.0000Historical High--Div YieldTTM13.37%Amplitude2.5300Historical Low3.2970Avg Price1Lot Size
NuCana Stock Forum
NEWS
NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement
Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy
Clinical Study
NUC-7738 Reprograms Cancer Cell Lipid Metabolism to Make Tumors Less Aggressive
and Promote Cancer Cell Death
NUC-7738 Alters Ribosome Biogenesis and the Regulation of Genes Critical for Cancer
Growth and Survival
San Diego, California April 9, 2024 (GLOBE NEWSWIRE)- NuCana plc (NASDAQ: NCNA) announced two posters be...
NEWS
NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study
NuCana plc (NASDAQ: NCNA) presented two posters at the AACR Annual Meeting showcasing the effects of NUC-7738 on cancer cell lipid metabolism and ribosome biogenesis. NUC-7738 was found to reprogram lipid metabolism in tumors, making them less aggressive and promoting cancer cell death. The drug alters genes critica...
No comment yet